Sign in

CIK 0001321834 · Non-accelerated filer<br>Smaller reporting company

Q/C TECHNOLOGIES, INC.

Sign in to watch
Ticker
QCLS
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
856-848-8698
Business address
1185 AVENUE OF THE AMERICAS, SUITE 249, NEW YORK, NY, 10036
Former names
Q/C TECHNOLOGIES, INC., TNF Pharmaceuticals, Inc., MyMD Pharmaceuticals, Inc., Akers Biosciences, Inc., Akers Biosciences Inc
  1. DEF 14A Proxy Proxy Statement
  2. PRE 14A Proxy Proxy Statement (Preliminary)
  3. DEF 14A Proxy Proxy Statement
  4. PRE 14A Proxy Proxy Statement (Preliminary)
  5. DEF 14A Proxy Proxy Statement
  6. DEF 14A Proxy Proxy Statement
  7. PRE 14A Proxy Proxy Statement (Preliminary)
  8. DEF 14A Proxy Proxy Statement
  9. PRE 14A Proxy Proxy Statement (Preliminary)
  10. DEF 14A Proxy Proxy Statement
  11. PRE 14A Proxy Proxy Statement (Preliminary)
  12. DEF 14A Proxy Proxy Statement
  13. DEF 14A Proxy Proxy Statement
  14. DEF 14A Proxy Proxy Statement
  15. PRE 14A Proxy Proxy Statement (Preliminary)
  16. PRE 14A Proxy Proxy Statement (Preliminary)
  17. DEF 14A Proxy Proxy Statement
  18. DEF 14A Proxy Proxy Statement
  19. PRE 14A Proxy Proxy Statement (Preliminary)
  20. DEF 14A Proxy Proxy Statement

Page 1 of 2 · 25 filings